| CANCER & TREATMENTS FOR CANCER CENTER PATIENTS PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER | ||
Home > Clinical Trials and Research > Clinical Trials Home > Defining Clinical Trials Denise Mouro, R.N., research nurse at the University of Michigan Comprehensive Cancer Center explains the
role of a clinical research nurse when it comes to clinical trials. Defining Clinical Trials, page 3Topic IndexOn page 1: On page 2:
Where do clinical trial volunteers come from?
On this page:Are there enough people volunteering for clinical trials?
Why are clinical trials important?
On page 4:What are the phases of a clinical trial?
Are clinical trials only for people in late stages of cancer?
Is it dangerous to be in a clinical trial? Why are clinical trials important?Without clinical trials, there would be no new treatments for cancer. Under most circumstances, doctors in the United States cannot treat patients with experimental drugs or treatments unless they have been carefully tested and licensed for patient use by the federal Food and Drug Administration. FDA experts analyze the results from clinical trials to determine whether new therapies are safe and more effective than established treatments. Without FDA approval, new cancer drugs or therapies cannot be marketed in the United States.What are the phases of a clinical trial?Clinical trials of new cancer drugs or treatments are conducted in a series of stages called phases:Phase I: researchers find out whether the experimental drug or treatment is safe for people and what side effects it causes. Phase II: researchers use phase II trials to find out if the experimental drug or treatment is effective against a specific type of cancer. Phase III: these studies (trials) are designed to compare, in matched groups of hundreds or even thousands of patients, the results from experimental treatment with results from conventional treatment. Unless the experimental treatment is shown to be safe and more effective than conventional treatment, it is unlikely to be approved by the FDA for general use in patients. Continue reading: page 1 | page 2 | page 3 | page 4
|
Browse Cancer Clinical Trials on UMClinicalStudies.org. |
|||||